Interventional Cardiology

Atrium’s vast expertise in developing technologies for the treatment of cardiovascular disease has brought breakthrough technologies to previously unmet clinical needs in interventional cardiology. These next-generation interventional technologies provide Atrium with a broad spectrum of innovative coronary products to achieve “total lesion” therapeutic care for even the most challenging patients. As a result of Atrium’s scientific advances in both biological and device technologies, we will continue to revolutionize the interventional cardiology market.

ClearWay™ RX is one of the latest advances in a series of unique medical device innovations built on our 25 year legacy of excellence in advanced polymers and biomaterial science. This revolutionary interventional drug delivery technology allows for more localized delivery with far less systemic payloads. Already proven in real-world livesaving applications, ClearWay™ RX will continue to lead the way in local therapeutic infusion.

Atrium’s latest development is a world-class stent platform with narrow struts and unique cell geometry. Utilizing proprietary crimping technology, Cinatra™ offers tremendous flexibility with a super low crossing profile to reach virtually every coronary target lesion.

Please contact Atrium’s Interventional Cardiology Systems team to learn more about our innovative coronary products and exciting therapeutic solutions currently in development.